Drug Type CAR-T |
Synonyms- |
Target |
Mechanism CD133 inhibitors(CD133 inhibitors), CD44 inhibitors(CD44 antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 31 Dec 2023 | |
Neoplasms | Preclinical | CN | 31 Dec 2023 |